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Abstract
Background: Primary care reforms should be supported by high-quality evidence across the entire life cycle of
research. Front-line healthcare providers play an increasing role in implementation research. We recently evaluated
two interventions for people with type 2 diabetes (T2D) in partnership with four Primary Care Networks (PCNs) in
Alberta, Canada. Here, we report healthcare professionals perspectives on participating in primary care
implementation research.
Methods: Guided by the RE-AIM framework, we collected qualitative data before, during, and after both
interventions. We conducted 34 in-person or telephone interviews with 17 individual PCN professionals. We used
content analysis to identify emerging codes and concepts.
Results: Two major themes emerged from the data. First, healthcare managers were eager to conduct
implementation research in a primary care setting. Second, regardless of willingness to conduct research, there
were challenges to implementing experimental study designs for both interventions. PCN professionals presumed
the interventions were better than usual care, expressed role conflict, and reported administrative burdens related
to research participation. Perceptions of patient vulnerability and an obligation to intervene exacerbated these
issues.
Conclusions: Healthcare professionals with limited practical research experience might not foresee the challenges
in implementing experimental study designs in primary care settings to generate high-quality evidence. These
issues are intensified when healthcare professionals perceive target patient populations as vulnerable and in need
of intervention based on the presenting illness. Possible solutions include further research training, involving
healthcare professionals in study design development, and using non-clinical staff to conduct research activities,
particularly among acutely unwell patient populations.
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Background
There is a need to transform primary care, and one of
the most important methods relates to conducting rigor-
ous implementation research [1]. Increasingly, front-line
healthcare providers are participating in implementation
research [2] and can influence the quality of trials and
the evidence generated [3]. However, we know little
about their perspectives on participating in primary care
research. Most studies focus on healthcare providers’
views of participating in traditional randomized con-
trolled trials, typically in academic or tertiary care set-
tings [2–8], and primary care related implementation
settings remain under-studied.
We recently evaluated the implementation of two in-
terventions for people with type 2 diabetes (T2D) in
partnership with four Primary Care Networks (PCNs) in
Alberta, Canada. PCNs are similar to the medical home
model in the US [9–11]. They are a network of physi-
cians and allied healthcare providers who provide com-
prehensive primary care tailored to local populations.
PCN healthcare professionals implemented the two in-
terventions, supported by our research team. Healthy
Eating and Active Living for Diabetes in Primary Care
Networks (HEALD) was a 6-month, exercise-specialist
led, pedometer-based walking intervention [12]. Team-
Care was a 12-month collaborative care intervention led
by a nurse care manager who coordinated the care of
patients with T2D and depressive symptoms [13]. Both
interventions were previously demonstrated to be effica-
cious in controlled studies [14–16], and proved effective
when implemented in Alberta’s PCN settings [17, 18].
As part of our detailed mixed-methods evaluation plans,
we employed the RE-AIM framework [19–21] a priori to
evaluate the implementation of both interventions [12,
13, 22]. Herein, we describe PCN healthcare managers
and providers’ perspectives on participating in primary
care implementation research.
Methods
Setting: primary care networks
We implemented HEALD and TeamCare in partnership
with four non-metro PCNs (i.e., serving an area of less
than 50,000 people) between 2010 and 2013. While
unique in structure, all four PCNs shared a chronic dis-
ease management mandate making them an ideal envir-
onment to adopt the interventions. Collectively, the four
PCNs represented 140 family physicians serving approxi-
mately 10,000 patients with T2D. Healthcare managers
and providers at the four PCNs had varying levels of ex-
perience participating in research, ranging from no ex-
perience to collaborating with research teams
responsible for implementing studies in the PCN setting.
We promoted PCN ownership of the research by align-
ing with their organizational values (e.g., chronic disease
mandate) and activities (e.g., existing diabetes, depres-
sion, and lifestyle counseling programs) [23], tailoring
protocols to each PCN (e.g., providing strategies to
achieve physician support, patient tracking template,
sample patient invitation letter) [24, 25], and providing
financial resources to undertake the interventions.
Research training
PCN managers recruited or seconded healthcare pro-
viders to deliver the interventions (i.e., exercise special-
ists for HEALD and nurse case managers for
TeamCare). The healthcare providers were responsible
for patient recruitment, screening, obtaining informed
consent, patient allocation to study arms, and data col-
lection and management. To ensure the integrity of the
research designs across sites, healthcare providers re-
ceived comprehensive resources and extensive training.
This included detailed project manuals, telephone
screening scripts, information letters and consent forms,
data collection forms and surveys, and instructions on
data entry and management (Table 1). We provided on-
site training and detailing sessions on informed consent,
data collection and management, and performing clinical
Table 1 Research protocols provided to PCN healthcare
providers, including documents, processes, and systems
Documents/processes/systems
➢ Project background, including development of the interventions
(HEALD and TeamCare)
➢ Contact lists (research team, participating PCN staff across sites)
➢ Protocol to achieve member physician support
➢ On/Off study design timetable/schedule
➢ Patient recruitment algorithm/study flow, including:
▪ Protocol for non-response to patient invitation letter
➢ Patient recruitment and tracking system (Excel)
➢ Short screening survey package, including:
▪ Sample patient invitation letter from PCN
▪ Information letter
➢ Eligibility & incentives, including:
▪ Inclusion/Exclusion criteria
▪ Incentive
➢ Telephone screening script and protocol
➢ Frequently Asked Questions
➢ Checklist for packages sent to participants (HEALD specific)
➢ Data collection matrix
➢ Clinical protocols/instructions for intervention and active control
groups, including:
▪ Informed consent
▪ Data collection of clinical & physical measures
▪ Discharge or end of study
➢ Information letters & consent forms
➢ Data collection forms & surveys
➢ Instructions for data entry & management
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and physical measures. In addition, we provided regular
quality assurance feedback and on-going support through
site visits, telephone and email communications (Table 2).
Study design
We described the overall evaluation [22] and the study
design for HEALD [12] and TeamCare [13] elsewhere.
To recruit for both interventions, healthcare providers
telephoned potential participants to establish willingness
to participate and confirm eligibility. Once confirmed,
healthcare providers allocated eligible patients using a con-
trolled “on-off” time-series method [26, 27]. This ‘alterna-
tion’ form of allocation is credible for health care quality
improvement studies, and resulted in no imbalances or de-
tectable biases between the intervention and control
groups [27]. Control group patients received usual care.
Data collection
Guided by the RE-AIM framework [22], we collected
qualitative data at baseline, midpoint, and post-
intervention for both interventions. The primary source
of data was interviews with healthcare managers (i.e., ex-
ecutive directors and managers of chronic disease pro-
gramming) and providers (i.e., nurse care managers and
exercise specialists) across the four PCNs who were in-
volved in the interventions. Using purposeful sampling,
we invited via email all healthcare managers and pro-
viders involved to participate in semi-structured inter-
views at three time points (i.e., baseline, midpoint, and
post-intervention), as appropriate, using interview guides
(Table 3). All invited participants agreed to interviews.
Participants were informed of the research goals. One
researcher (LW) conducted and digitally recorded 34 in-
terviews with 17 individuals, either in-person at the
PCN offices or by telephone. Interviews were 30 to
120 min in length and were transcribed verbatim by an
independent transcriptionist and verified for accuracy.
The Health Ethics Research Board of the University of
Alberta deemed this qualitative component of the inter-
vention studies exempt from review [22].
Data analysis
We used an inductive, content analysis approach to iden-
tify emerging codes and concepts related to participating
in implementation research in the primary care setting, as
this is the most appropriate analytic technique for an ex-
ploratory qualitative study [28, 29]. Emerging codes and
concepts were discussed during formal research team
meetings and discrepancies resolved by consensus. Data
saturation was achieved through interviewing all key in-
formants involved in implementing the research and inter-
vention activities across the participating PCNs. We used
several verification strategies [30], including methodo-
logical coherence, appropriate sampling, and concurrent
data collection and analysis [30]. We participated in pro-
longed engagement with the PCNs [29, 31] (e.g., devel-
oped and maintained a 4-year partnership), member
checking [31], and peer debriefing [28]. To ensure partici-
pant and PCN confidentiality, we used study codes for
highlighted quotes reflecting respondents (i.e., managers
or providers) and intervention (i.e., “HD” for HEALD and
“TC” for TeamCare). Data were managed using Nvivo 10
(Burlington, MA, QSR International (Americas) Inc.) [32].
Results
Two major themes emerged regarding participating in
primary care implementation research. First, healthcare
managers were eager to participate in primary care im-
plementation research. Second, regardless of the willing-
ness to participate in research, there were challenges
implementing experimental study designs and protocols
for both interventions. Healthcare managers and pro-
viders presumed the interventions were better than
usual care, experienced role conflict, and reported par-
ticipating in research as administratively burdensome.
We found that perceptions of the vulnerability of the pa-
tient population and duty to intervene based on severity
of the presenting illness exacerbated these issues. We
provide illustrative quotes for each theme and additional
supporting quotations in Table 4.
Theme 1: eager to participate in primary care
implementation research
At baseline, healthcare managers reported being eager to
support and conduct implementation research in the
Table 2 Summary of training activities/supports provided to
PCN healthcare providers responsible for implementing the
study designs
Training activities & supports by research
team
Members of the PCN
team
▪ Individual detailing sessions on:
▪ Obtaining informed consent
▪ Data collection and documentation (e.g.,
assigning study IDs)
▪ Data management (e.g., proper secure
storage of patient files)
▪ Patient recruitment algorithms/study
flow, including mail out of screening
survey packages and reminder postcards
▪ Eligibility criteria
▪ Telephone screening script & protocol
▪ Preforming clinical and physical measures
▪ Exercise specialists and
care managers
▪ Administrative personnel
▪ On-site training on patient recruitment &
tracking system (e.g., Access database)
▪ Exercise specialists and
care managers
▪ Administrative personnel
▪ On-site Point of Care training ▪ Exercise specialists and
care managers
▪ On-going support by research team via
regular in-person PCN site visits, telephone,
electronic mail, and quarterly bulletin
▪ Exercise specialists and
care managers
▪ Administrative personnel
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primary care setting to prove effectiveness of interven-
tions and to use the evidence to inform decisions around
programming and sustainability (i.e., business planning):
Number one, we’re a PCN that really does support
research (PCN manager-HD/TC).
It will, regardless of what the results show…, it’s going
to inform business planning (PCN manager-HD/TC).
However, PCN managers and providers perceived the
interventions as university-based research studies, not
PCN programs, despite our efforts to promote ownership:




Baseline ED & CDM Why did your PCN decide to implement and deliver HEALD and TeamCare? In other words, why did you
think the interventions were a good fit for your PCN?
Describe why you provided a rating of Xc to describe the level of commitment of the PCN leadership
(i.e., PCN Board and/or Management) to the HEALD and TeamCare interventions.
At this time, do you believe that PCN staff is capable of implementing HEALD and TeamCare? Why?
At this time, do you believe HEALD and TeamCare are appropriate for PCN staff, patients, and/or PCN
member physicians? Why?
What are the anticipated benefits of HEALD and TeamCare, if any, for staff? What are the anticipated
disadvantages, if any, to staff?
Do you have any other comments about HEALD or TeamCare?
Midpoint ED, CDM, CM, & ES To date, what were the challenges or barriers in getting HEALD and TeamCare up and running? How were
these challenges or barriers addressed?
To date, what has worked well in getting HEALD and TeamCare up and running?
Looking back, what would you have done differently or do you think should have been done differently.
What advice or recommendations would you give to someone else in your position that is about to
implement HEALD and TeamCare into their organization?
What assumptions did you make about HEALD and TeamCare (e.g., your role, interventions, how it was
going to work)?
In your opinion, are HEALD and TeamCare sustainable? If yes, how do you see this being achieved? If no, why?
Do you have any other comments about HEALD or TeamCare?
Post-Intervention ED, CDM, CM, & ES During your midpoint interview, we focused mainly on implementation of TeamCare. Do you have anything
else to add regarding what worked well, what didn’t work well, and suggestions for improvement?
Thinking back to when we first asked you to be involved, what assumptions did you make about HEALD and
TeamCare (e.g., your role, the intervention, how it was going to work)?
In your opinion, should the PCN continue to use this model of care (i.e., HEALD and TeamCare)? Why or why not?
ED & CDM What components, if any, of HEALD and TeamCare will be sustained in your PCN? Describe how each
component will be sustained.
What components, if any, of HEALD or TeamCare will not be sustained? Describe the barriers to sustaining
these components. What would make it sustainable?
CM & ES Tell me about your (job) satisfaction in this role compared to your previous roles.
Based on your experience, would you consider doing this role again? Why or why not?
What will you take, if anything, from your experience with HEALD and TeamCare into your future work/roles?
ED, CDM, ES, & CM Do you have any other comments about HEALD or TeamCare?
ED executive directors who were responsible for supervising the CDM and ES
CDM chronic disease managers who were responsible for supervising the CDM and ES
CM Nurse care managers who were responsible for implementing the research and intervention activities for the TeamCare intervention
ES exercise specialists who were responsible for implementing the research and intervention activities for the HEALD intervention
PCN primary care network
aKey informant groups were interviewed based on timing of the interventions and relevance to their role. For example, exercise specialists and care managers
were not asked baseline interview questions because they were not involved in the decision to implement the interventions at each PCN. In addition, exercise
specialists were not asked to comment on the TeamCare intervention because they were not involved in its implementation
b Key informant groups were asked each interview question separately for the HEALD and TeamCare interventions
c The rating was elicited through the following question asked in the usual care checklist: Considering all the competing priorities your PCN has, what is the level
of commitment of the PCN leadership (i.e., PCN Board and/or Management) to the TeamCare-PCN intervention on a scale of 1 to 10, where 1 is “not a priority at
all” and 10 is “highest priority of all”?
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Table 4 Supporting quotations by themes and key findings
Key findings Supporting quotation(s)
Theme 1: Eager to participate in primary care implementation research
▪ Supportive of implementation research in primary
care setting to determine effectiveness of
interventions and to use evidence to inform
decision-making
I mean it’s participating in research, definitely. Because we want to prove what we’re doing is
working, right? Or else, why are we here? (PCN manager-HD/TC).
So there are millions of dollars being spent and very little actually researching whether it’s
effective or if there are better ways to do it… (PCN manager-HD/TC).
Looking at more informing our future business planning…We have two years to evaluate how
effective this is and it’s a really easy sell for the Board after the fact to say, look, this is the
effect of it (PCN manager-HD/TC).
I think that the results are going to be important in terms of trying to actually put some
dedicated funding into the continuation of it. Often with research, we’re there with the
resources, but then once the research project finishes, the reserves are spent. So really making it
a continued priority in the PCN, to continue putting resources towards these two projects…
with the business planning process (PCN manager-HD/TC)
▪ Implementation research perceived as
external to PCN (i.e., university-based)
Right now it’s a research study. But I think as [TeamCare] becomes more of a way of doing
business, more physicians would come onboard. Because it is the way we practice then (PCN
manager-TC).
I mean even though I was housed within the PCN, I didn’t always necessarily feel like I got the
support from the other PCN team members… But I think it was easier rather than trying to
understand [HEALD] and continuing to fail, I think it was almost easier for them to just
pretend, oh they didn’t exist, right? Like pretend that “HEALD, oh that’s the research study and
they’re doing their own thing”, rather than, “Okay how can we work as a team and how can – how
can we help you?” (PCN provider-HD).
As far as [the exercise specialist], that was completely outside of anything we were doing [at
the PCN]. So she was really working with you guys. It didn’t affect us at all (PCN manager-HD).
Theme 2: Challenges to conducting primary care implementation research
➢ Interventions presumed better than usual care
▪ Study design is not appropriate for this stage
of research
Honestly, the on-off [design] has been one of the major challenges. And I know in a pure research,
laboratory, very scientific methods, it makes abundant sense to do that because that is the gold
standard, right? But in reality, I think that’s why you see so few people-related studies that are
having an [intervention and active-control] group – unless it’s like a pharmaceutical double
blind (PCN manager-HD/TC).
The on-off design? What I would do differently primarily would be… to my perspective, this
was an implementation study and so the reality is, we have existing services. So the [control
group] would be reasonable to use that with our existing [PCN] services…Rather [than] coming
in with the attitude of “You are not effectively managing patients, let us show you how to do
it, and so we’re going to, on our island, tell you how things should be done” – I feel that that
was a really unfortunate approach. Because the existing services are very similar, at least within
our PCN – very, very similar… Rather than saying, you know, “on-off - we just don’t take care
of these people”. [Instead, for the active-control arm], this is usual care, using our mental health
coordinators, and wouldn’t it be nice if the results are actually equally as positive (PCN provider-TC).
▪ Poor patient engagement and retention of control
group patients, specific to TeamCare
The challenge I’m having now is the [active-control group] people, they’re just not as engaged,
of course. And to get them to come back in for their six-month [data collection appointment]
is very challenging, you know? And we’ve had a few that have dropped out… But right now,
my major challenge is to get those people in who are due for their six months who are [in the
active-control group]. Yeah, it’s a lot of phone calls, you know, and follow-up with them and it
is a challenge to get them. It’s almost like, “what’s in it for me”, you know? (PCN provider-TC).
[The care manager] and I were just talking about it, not too long ago, saying, well that [active-
control] group – what’s the incentive for them to come back in six months? You know? And
that’s probably where you lose a lot of people, the attrition is that “what’s the point of coming
back? They didn’t do anything the first time for me, what are they going to do the second
time”? (PCN manager-TC).
Having an unblinded study where there’s the [intervention] group and the [active-control]
group and then this [active-control] group doesn’t really get anything from us other than
having to fill out questionnaires. So I think that in itself was a bit of a difficulty to keep people
in the study, difficult to keep them interested if they were proposed that, “Okay, this is the
consent. By the way, you’re in the [active-control] group”, and then they’ll be like “Well what’s
in it for me?” Right? (PCN provider-TC).
▪ Difficulty referring control group patients to usual
care, specific to TeamCare
We have to go back to the physician and the physician has to refer them [to the PCN]. And if
that physician isn’t engaged with the PCN and what we have to offer, that patient doesn’t get
seen, even though they may score high on their testing. So that’s been very difficult for us.
Hands off (PCN manager-TC).
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Table 4 Supporting quotations by themes and key findings (Continued)
➢ Role conflict
▪ Experimental study design conflicts with
professional commitment to provide care
Yeah, ‘cause it’s against what we – like you’re here to help people and it kind of goes against
your grain to not be able to say “Well we could help you with that”, or “the [PCN] program
here is great” or [city name] mental health, here’s their number… because we’ve had other
people who’ve done really well with some small changes to their medication [in TeamCare]. So
you want that for everyone (PCN provider-TC).
I think one of the things that we’ve talked a little bit about here as one of the challenges is…
it’s sort of the [intervention] and [active-control] group idea, right? Like ‘cause obviously it’s
been really hard for the nurses to say, “Well you know, you’re demonstrating all these
symptoms and maybe you’re not managing so well with your diabetes but you can’t be part
of the program”. And so that’s been a bit of a struggle for us, for sure… I know it was hard for
the nurses to say, “Sorry” (PCN manager-HD/TC).
So that way you wouldn’t have this group of people that you feel some of them have been
the people that needed it the worst, you know? Looking at their PHQ scores and talking with
them even just a brief amount of time that you talk. Actually some of them I’ve spent quite a
bit of time talking to because they’re a 20 [on the PHQ]. You can’t really offer them everything.
You think, “Oh I’d really like to follow up this individual” and you can’t do it. So it’s kind of
annoying – not right. Morally not right for them. So that’s one thing I would change (PCN
provider-TC).
▪ Discomfort with experimental study design
(e.g., unethical or immoral), specific to TeamCare
Well I still have a hard time with the [active-control] group. Like I have to say like yesterday I
had a client who scored 21 [on the PHQ]. Like I would have maybe liked to see this as a pilot
project and then evaluate rather than having the intervention and non-intervention. I don’t
know. It just feels sometimes unethical to bring people in – especially if their score is high. Like
if they’re ten – but this fellow yesterday, just as an example, he was 21, his A1c was 11.1, his
lipids were all elevated, blood pressure – and then I had to say, “Hmmm. Well thanks for coming –
thanks for coming out”. So that feels unethical to me somehow ‘cause we know we could offer
something more. So … I have a hard time with that (PCN provider-TC).
It’s an ethical clinical issue, yes. There’s research protocols…that will always be less significant
than somebody’s physical safety. And that’s not a negotiable for me…compared to “is
someone appropriately being treated for the risk of suicide”…The issue was “here’s the bigger
picture” – patient safety should, in my mind as a clinician, have to come [first] – and it didn’t
feel like it was. And that’s hard to do as a nurse. Especially as a legally - you know, as the legal
expectation for myself that I would not compromise in any other setting. (PCN provider-TC).
That way you wouldn’t have this group of people that you feel that some of them have been
the people that needed [the intervention] the worst. Like looking at their PHQ scores and
talking with them even just a brief amount of time - actually some of them I’ve spent quite a
bit of time talking – because they’re a twenty [score on PHQ]… you can’t really offer them
everything. You think, “Oh I’d really like to follow up this individual” and you can’t do it. So it’s
kind of annoying, not right. Morally not right for them (PCN provider-TC).
We’ve all had a really hard time with those patients in the [active-control] group. And that’s so
hard on our staff. That has been a very hard thing because we have a mental health liaison
that would be the natural fit. That’s what we would naturally do. It is. But we can’t tell
[patients] that. We have to go back to the physician and the physician has to refer them. And
if that physician isn’t engaged with the PCN and what we have to offer, that patient doesn’t
get seen, even though they may score high on their [PHQ]. That’s been very difficult for us.
Hands off…And, what about ethics? Where does ethics play in something like that? Because,
really, that’s not ethical (PCN manager-TC).
▪ Recommendations to modify the study design Well, I guess my surprise was the on-off [design], right? I had some concerns about that initially.
And I talked to [the Research Program Manager] about it and, I think as a team, you likely had
some concerns about that as well. But we’re committed, that’s how the approval was given and
so you get committed to certain research models and so on. So I do get that. I just I think it’s
unfortunate that there couldn’t have been some reassessment of that somewhere along the
line. Because I do think it’s quite a strong [intervention]. I think it has the potential to help a
lot of people (PCN manager-TC).
○ Patients act as own controls using histories I’m not sure that you’re going to get better data or better results by having had this group of
people that didn’t get the protocol. They could have been their own control group and then
look at how many more people we could have offered it to (PCN manager-HD/TC).
Or if you would want to maybe have everybody be intervention and look at their past history
to be the non-intervention. Like what were they like before? What were their two years prior.
Their own controls, yeah… I’m not sure that you’re going to get better data, or better results
of having had this [active-control] group of people that didn’t [get the intervention] – that the
protocol could have given to them (PCN provider-TC).
○ Carefully match patients I think people can be their own controls or you can carefully match (PCN manager-HD/TC).
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If it was just brought to the PCN and it wasn’t a study
and things like that, I think I would be more engaged
in it because I would have adopted it as our program
that’s staying… (PCN manager-TC).
Therefore, healthcare managers and providers viewed
implementation research as external to the PCNs.
Theme 2: challenges to conducting primary care
implementation research
Regardless of the initial willingness of healthcare
managers to participate in research, implementation
of the experimental study designs proved challenging
for both interventions due to presumed effectiveness
of the interventions, role conflict, and administrative
burden.
Interventions presumed better than usual care
It appears that healthcare managers and providers
had a negative perception of usual care and presumed
the interventions would improve patient care at the
outset of the study. Once implemented, they per-
ceived the experimental study design as inappropriate
for this stage of research because the interventions
had been demonstrated efficacious in randomized trial
settings:
Table 4 Supporting quotations by themes and key findings (Continued)
○ Focus on qualitative rather than quantitative
evidence
I know there’s other ways of doing research. I don’t know if you want it to be more qualitative
than quantitative (PCN provider-TC).
➢ Administrative burden
▪ Examples: scheduling data collection appointments,
data entry
Initially and ongoing trying to fit into my schedule all the admin and the phone calls and the
scheduling and rescheduling if people can’t make appointments and doing that on top of my
other duties that I have to do has been quite a challenge (PCN provider-HD).
There’s more paperwork involved than I originally anticipated – a lot more tracking of stuff.
Like I’ve got binders that – I’ve got so many binders, just like wow!…For example, we have a
binder for writing down all the patient appointments. And I have that in my schedule so it’s a
bit tedious to have to go into another thing and write them in there… And then we have the
binder with informed consent and everybody’s information page. And then we’ve got another
binder for, you know? There’s just lots of tracking and paperwork and lots of stuff on the
computer. I didn’t realize that it would be that much (PCN provider-HD).
I feel like I was way too busy doing my own admin work to really worry about what else was
going on. So I feel like, you know, there were times where the workload was ridiculously heavy.
But it’s more in those recruiting stages, right? And then it kind of tapers off and you see your
patients and then that’s it, right? And then you have your next wave of recruiting (PCN
provider-HD).
A challenge that I found was actually keeping up with [data entry in the Care Manager
Tracking System (CMTS)] because I was part-time and I felt like I was double charting, right?…
I found it overwhelming sometimes… But the part that always hung me up was that extra
charting in the CMTS so that was where I did actually appreciate, again, the support [from the
research team]– just for the quirkiness of that actual database as well as just the accountability of
actually getting it done (PCN provider-TC).
▪ Preferred passive patient recruitment and voluntary
or engaged patient population
At times I felt it was [the PCN’s] responsibility to find these participants for the study. I think it could
have been pre-arranged, do you know what I mean? …Maybe doing an ad in the newspaper to
get more participants, maybe going to the doctors’ offices and advertising a little bit more probably
would have increased the numbers in the study. But not me doing that. I think that should
have been done before. So that the numbers were already there, the participants were already
volunteering to participate (PCN provider-HD).
▪ Decreased satisfaction related to research role,
specific to HEALD
The paperwork was a bit… I mean, there’s a lot of paperwork with it, right? So that wasn’t my
favourite part of it… Less paperwork and less stuff around “You gotta invite these people at
this time”… Well you know, as exercise specialists, we’re all action and let’s – don’t bother me
with the details kind of thing. Let’s go walking or something, you know? (PCN provider-HD).
Now I understand that with, like it’s research so it had to be the way that it is and I think that
that probably impacted my level of satisfaction with it. I mean I did really enjoy working in the
group setting and I really think that at the end of the day just working with the people is what
I enjoy (PCN provider-HD).
I would consider doing [this role] again in a different capacity, with making some of the
modifications that we’ve already discussed. And then in fact just doing the model. And not all
the other [research] things (PCN provider-HD).
Well [I was] surprised by all the admin work because it’s not something I really enjoy doing
(PCN provider-HD).
HD Healthy Eating and Active Living for Diabetes in Primary Care Networks (HEALD) intervention
PCN primary care network
TC TeamCare intervention
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My way of thinking, we would have had a lot more
buy-in, since this is already a protocol that has been
proved in other places to have worked. We’re not really
necessarily testing the protocol so much as the
applicability to this population. Honestly, is there
that much difference between Canadians and Americans
as far as whether or not a protocol would work?
(PCN provider-TC).
Specific to TeamCare, healthcare managers and pro-
viders perceived poor patient engagement and retention
among control group patients because they believed
there was “nothing in it” for those allocated to usual
care:
[The care manager] shared with me that getting people
in the [control group]… they’re just not coming back in
[for data collection appointments]. And really, why
should they? There’s nothing in it for them (PCN
manager-TC).
In addition, healthcare managers and providers expressed
concern referring control group patients to usual care, es-
pecially for TeamCare, because patients may not access
care or physicians might not refer patients to existing
PCN programs and services:
Is the client gonna really go back to the doctor? I have
no control over that. He may say “Yeah I’ll go” but
whether he actually goes – I’m not following him up in
two weeks and saying “Hey, did you get over to your
doctor yet?” (PCN provider-TC).
Their anxiety intensified when they allocated patients
they perceived as most in-need (i.e., patients who have
“fallen through the cracks”, experiencing symptoms, or
struggling to manage their condition) to the control
group:
This fellow yesterday, just as an example, he was 21
[on the PHQ]… his A1c was 11.1, his lipids were all
elevated, blood pressure. And then I had to say,
“Hmmm. Well thanks for coming out”. So that feels
unethical to me ‘cause we know we could offer
something more. So I have a hard time with that. This
fellow yesterday, he said, “I feel like my wife and I are
falling through cracks”, and here he gave a hand out
and I had to say, “Well thanks for coming out. Go
back to your doctor” - you know? Just didn’t seem
right…Can we make him in my [intervention] group?
Could I switch him? And then when he says things
like, “I feel like my wife and I have fallen through the
cracks”, it’s like oh here’s another one, you’re falling
through the cracks ‘cause – he’s so depressed, he feels
like he’s on a treadmill. He feels like giving up. He feels
like jumping off a bridge. So now I have to say
“Hey wait a minute, go back to your doctor” rather
than saying “Hey, why don’t you come back next
week and see me and we’ll talk some more about
this” (PCN provider-TC).
Indeed, we observed an imbalance in TeamCare en-
rollment with 95 patients assigned to the intervention
group and 62 patients assigned to the control group
[27]. While the groups had similar characteristics, the
imbalanced numbers may reflect attempts of healthcare
providers to enrol patients into the intervention group.
However, this was not the case for HEALD, where the
groups were more balanced numerically [27]. As a
strategy to alleviate healthcare managers and providers’
concerns with the design, TeamCare study design
allowed control group patients to cross over into the
intervention group once they completed the control
group cycle and if they were still experiencing depres-
sive symptoms [27].
Role conflict
At baseline, healthcare managers and providers did not
express concern implementing the “on-off” design for either
intervention. However, during mid- and post-intervention
interviews, they reported challenges implementing the de-
sign. This arose largely from conflict between the health-
care providers’ roles as researchers and their professional
principles and training as care providers. In particular,
interacting with control group patients (e.g., conducting
baseline allocation and data collection) went against their
commitment to provide care, problem-solve and offer
services:
It may be easier if somebody is used to research, this is
just the way it goes. So you pull somebody in who’s a
primary caregiver and put them into a position where
they’re used to solving problems, they’re used to
making suggestions. That’s what you do and then you
take that away from them. It’s like you strip that
ability away from them (PCN manager-HD/TC).
Specific to TeamCare patients, the discomfort experi-
enced by healthcare providers was extreme with many
describing the experimental study design as unethical or
immoral:
We’ve all had a really hard time with those patients in
the [active-control] group. And that’s so hard on our
staff…That’s been very difficult for us. Hands off…And,
what about ethics? Where does ethics play in
something like that? Because, really, that’s not ethical
(PCN manager-TC).
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For these reasons, healthcare providers recommended
modifying the study designs by using patients as their
own controls, carefully matching patients, or focusing
on qualitative rather than quantitative evidence:
As far as ongoing challenges, I still think that the
[control] group and the design methodology has been a
major barrier to success. And in the future, I have a
very strong recommendation that the design
methodology be reconsidered (PCN manager-HD/TC).
Administrative burden
In addition to presumed intervention effectiveness and
role conflict, healthcare providers identified the amount
of administrative work as a challenge in implementing
research in the primary care setting. Examples of bur-
densome administrative tasks included scheduling data
collection appointments and conducting data entry for
both interventions:
I just hate it. I hate making phone calls! That’s
probably my least favourite is doing the follow-up calls
and leaving the same message and asking the same
questions… It’s a lot of calls! Boy. It is a bit tedious after
a while. So I’ll be glad when I can teach the classes
and not have to do the follow-up calls anymore!
(PCN provider-HD).
I was surprised by the amount of paperwork… it was
entering it on to the paper and then into the computer
as well. I don’t think there is a different way around it.
It needs to be done and it’s just part of the study (PCN
provider-TC).
Healthcare providers also discussed their role in
recruiting patients and preferred passive recruitment to
active screening:
I think another potential that we have promoted within
the PCN is using our own [existing] patients. So when
we identified a newly diagnosed [diabetic], we would
screen them ourselves potentially for depression…And
then the other thing I don’t think we have done is other
means of recruitment. So going to the paper, looking at
just the general population ‘cause there are a population
of people out there that are interested in participating in
studies (PCN provider-TC).
This reflects the typical pattern of healthcare providers
offering interventions to patients who seek care, rather
than systematically identifying and proactively contact-
ing targeted patients at a population level.
Specific to HEALD, exercise specialists reported dis-
satisfaction with their role participating in research.
They indicated they would do this role again without the
research component, because their priority is patient
care, not administrative tasks:
Working with patients is, for me, the satisfaction.
Having to do the recruitment and the admin…that’s
not what I want to do… I want to spend my time with
the patients (PCN provider-HD).
Discussion
In exploring the perceptions of healthcare managers
and providers involved in two implementation research
studies, we found two major themes. First, healthcare
managers were eager to conduct implementation re-
search in a primary care setting. Second, regardless of
willingness to participate in research, there were chal-
lenges to implementing protocols and experimental
study designs for both interventions. Healthcare man-
agers and providers presumed the interventions were
better than usual care, expressed role conflict, and re-
ported administrative burdens related to participation
in research. Importantly, their perceptions of patient
vulnerability and an obligation to intervene exacerbated
these issues. In summary, our findings demonstrate a
separation in the participants’ minds of: (1) the inter-
vention, which is perceived as proven and valuable with-
out further scrutiny, (2) its delivery, which is seen as
unproblematic and a component of providing care, and
(3) the research activities to determine its effectiveness,
which are seen as unnecessary and burdensome, except
among the higher echelons to justifying funding of a
service.
Our findings were similar to those reported in other
studies on healthcare professionals’ perspectives toward
research, including valuing research [6, 33], a commit-
ment to gathering evidence [2], and expectations of use-
ful clinical knowledge as an outcome [6]. However, we
found that, in general, healthcare managers and pro-
viders presumed the interventions were better than
usual care at the outset of the study. Healthcare pro-
viders in other studies have also expressed discomfort
and defensiveness related to role conflict as both re-
searchers and providers [2, 4, 6], including moral distress
[5]. They asserted their professional training and ac-
countability took priority over research [2, 3, 5–8] po-
tentially leading to intervening in patient care outside of
the defined study protocol. As such, professional training
as caregivers may compromise adherence to study pro-
tocols [4] and potentially dilute intervention effective-
ness [5, 6]. For example, nurses in one study described
providing increased patient-provider contacts, additional
referrals, advice, and links to support groups to trial pa-
tients citing the provision of extra care was in the best
interest of patients [4].
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We found role conflict among healthcare providers in-
tensified when they perceived the target patient popula-
tion as vulnerable and in need of intervention based on
the severity of their presenting illness. Indeed, others
have highlighted challenges healthcare providers face
participating in research based on the nature of the pa-
tient population. For example, physicians expressed diffi-
culties suspending clinical judgment in assessing patient
eligibility for a trial, particularly in recruiting patients
they perceived as acutely unwell (e.g., young men with
aggressive tumors) [2]. Similarly, nurses had “empathetic
preferences” where they perceived certain interventions
as less desirable for certain types of patients (e.g., ser-
iously ill children) [6]. In our case, nurse care managers
reported difficulties assigning depressed patients to the
control group. This did not appear to be the case for the
exercise specialists in assigning non-depressed but sed-
entary patients to the control group.
Lastly, we found that healthcare providers perceived
participating in primary care implementation research as
administratively burdensome. We found some healthcare
providers did not want to recruit patients actively into
the intervention studies at a population level, preferring
passive recruitment of volunteers that presented for
care, as is typical in day-to-day practice. However, rely-
ing on a voluntary population excludes diverse and high-
risk patients (e.g., those with comorbidities, diverse eth-
nicities, or limited engagement with healthcare services)
[21, 34]. In particular, the exercise specialists who imple-
mented HEALD perceived administrative tasks and
documentation in direct competition with providing pa-
tient care. Similarly, Spilsbury et al. [3] reported a lack
of compliance with trial protocols among healthcare
providers due to perceived “documentary burden”. The
authors [3] found that staff perceived completion of trial
paperwork as extra work that was a “tick box” procedure
rather than fundamental to good patient care, which re-
sulted in variable quality of data collected. These atti-
tudes may have implications for practice and healthcare
reform, beyond the realms of implementation research.
Our findings demonstrate a complex interplay between
healthcare professionals’ presumption that interventions
proven effective in similar settings are better than usual
care and role conflict through the obligation to intervene
in patient care based on the patient population targeted
and the severity of the health condition. In addition, re-
cruitment and systematic documentation was perceived as
a burden of participating in research, rather than compo-
nents of quality patient care. While we must address these
issues when undertaking primary care implementation re-
search, adapting study designs and protocols to mitigate
these issues may compromise research quality (e.g., low
quality data, inadequate rigour, and poor level of evi-
dence). Acknowledging the complexities derived from our
findings, we argue researchers must work to balance the
conduct of rigorous implementation research while main-
taining positive working relationships with staff of the
healthcare organizations where this type of research must
be conducted. In addition, engraining the values and prac-
tices of regular and ongoing quality management and im-
provement (e.g., data collection and rigorous evaluation)
of health care delivery in the basic training of all health-
care providers would likely strengthen implementation re-
search, as well as primary care reform.
Despite its strengths, our work has some limitations.
First, our participants and their PCNs were relatively re-
search naïve, and it might be that they would not per-
ceive the same role conflicts and burdens during the
next implementation study or with a different study de-
sign. Second, our findings are based on the experiences
of health providers from four voluntary, non-metro
PCNs that may not be representative.
Conclusions
Healthcare managers and providers with limited prac-
tical research experience might not foresee the chal-
lenges in implementing experimental study designs and
protocols in primary care settings to generate high-
quality evidence. These issues become exacerbated in
context of the patient population targeted and severity
of their presenting illness. These findings are relevant to
those designing and conducting implementation re-
search in primary care settings, and our work and others
present some possible solutions. First, it may be worth-
while to provide research training, support, and capacity
building to healthcare providers that address the prac-
tical challenges of participating in primary care research
[2, 3, 5–8, 33]. Second, researchers should involve
healthcare providers in research planning and develop-
ment a priori, including determining type of study de-
sign and eligibility criteria [2] based on assessment of
the patient population and perceived severity of the
health condition to address the moral obligation to pro-
vide care [5]. Third, it may be unrealistic to ask health-
care providers to balance two roles (e.g., research nurse
versus clinical nurse), which have competing demands,
interests, and ethics, and use of non-clinical staff may be
necessary to perform research tasks [2, 5, 6] particularly
with acutely unwell patient populations.
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